Related Experiment Video
Updated: May 2, 2026
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
Peptide-pulsed dendritic cells have superior ability to induce immune-mediated tissue destruction compared to peptide
Dilan Dissanayake1, Kiichi Murakami2, Michael D Tran2
1Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Abstract:
Vaccines for cancer immunotherapy are of interest but in general have not yet achieved the desired therapeutic efficacy in clinical trials. We present here a novel model to evaluate vaccine strategies by following tissue destruction in a transgenic model, where a defined antigen is expressed on pancreatic islets. We found that the transfer of syngeneic antigen-pulsed dendritic cells (DCs) resulted in autoimmune cytotoxic T-lymphocyte activation that was not observed following vaccinations that were based on peptides and adjuvants. Importantly, the induction of diabetes by DC transfer is dependent upon the maturation of DCs prior to transfer. Furthermore, diabetes induction only occurred if DCs were pulsed with the immunodominant epitope in addition to at least one other peptide, suggesting greater cytolytic activity upon engagement of multiple T-cell specificities. While the tumor environment undoubtedly will be more complex than healthy tissue, the insights gained through this model provide useful information on variables that can affect CD8-mediated tissue cytolysis in vivo.
Insights
Dendritic cell (DC) vaccines effectively activate cytotoxic T-lymphocytes for cancer immunotherapy, unlike peptide vaccines. Mature DCs pulsed with multiple antigens show enhanced autoimmune responses in a novel transgenic model.
Area of Science:
- Immunology
- Cancer Research
- Vaccinology
Background:
- Cancer immunotherapy aims to harness the immune system to fight cancer.
- Current cancer vaccines, including peptide-based approaches, often show limited therapeutic efficacy in clinical trials.
- Developing effective vaccine strategies requires robust preclinical models to assess immune responses and tissue destruction.
Purpose of the Study:
- To present a novel transgenic model for evaluating cancer vaccine strategies.
- To investigate the efficacy of antigen-pulsed dendritic cells (DCs) versus peptide-based vaccines in inducing autoimmune responses.
- To identify key factors influencing CD8-mediated tissue cytolysis in vivo.
Main Methods:
- Utilized a transgenic mouse model expressing a defined antigen on pancreatic islets.
- Administered syngeneic antigen-pulsed dendritic cells (DCs) and peptide-based vaccines.
- Monitored autoimmune cytotoxic T-lymphocyte activation and tissue destruction (diabetes induction).
- Investigated the role of DC maturation and antigen specificity in vaccine efficacy.
Main Results:
- Transfer of mature, antigen-pulsed DCs induced autoimmune cytotoxic T-lymphocyte activation and diabetes.
- Peptide-based vaccine strategies did not elicit comparable autoimmune responses.
- Diabetes induction by DC transfer was dependent on DC maturation.
- Optimal DC-mediated cytolysis required pulsing with the immunodominant epitope plus at least one other peptide.
Conclusions:
- Mature, antigen-pulsed dendritic cells are potent inducers of autoimmune responses, suggesting potential for cancer immunotherapy.
- Vaccine strategies involving mature DCs and multiple T-cell specificities may enhance CD8-mediated tissue cytolysis.
- This model provides valuable insights into factors affecting in vivo tissue destruction relevant to cancer vaccine development.
Related Concept Videos
01:22Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
01:40Cell-mediated Immune Responses
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:26Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...